Overview

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Status:
RECRUITING
Trial end date:
2030-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2b study to evaluate the efficacy and safety of IMVT-1402 in adults with CIDP.
Phase:
PHASE2
Details
Lead Sponsor:
Immunovant Sciences GmbH